Hyperkalemia resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 40: Line 40:
{{familytree | | | C01 | | | | | | | | | | | C02 |C01=[[EKG]] changes;e.g. hyperacute T waves, widened QRS,|C02=[[EKG]] not changed, patient stable}}
{{familytree | | | C01 | | | | | | | | | | | C02 |C01=[[EKG]] changes;e.g. hyperacute T waves, widened QRS,|C02=[[EKG]] not changed, patient stable}}
{{familytree | | | |!| | | | | | | | | | | | |!|}}
{{familytree | | | |!| | | | | | | | | | | | |!|}}
{{familytree | | | D01 | | | | | | | | | | | |!|| D01= Use rapidly acting transient agents,e.g [[Insulin]], [[Dextrose]], IV [[Calcium]]; with [[Ca gluconate]] generally preferred over [[Ca chloride]], inhaled [[beta2-adrenergic receptor agonist|Beta2 agonists]]}}
{{familytree | | | D01 | | | | | | | | | | | |!|| D01= Use rapidly acting transient agents, e.g [[Insulin]], [[Dextrose]], IV [[Calcium]]; with [[Ca gluconate]] generally preferred over [[Ca chloride]], inhaled [[beta2-adrenergic receptor agonist|Beta2 agonists]]}}
{{familytree | | | | | | | | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | |,|-|-|-|-|-|+|-|-|-|-|-|.|}}
{{familytree | | | | | | | | | | |,|-|-|-|-|-|+|-|-|-|-|-|.|}}

Revision as of 19:36, 23 July 2013

WikiDoc Resources for Hyperkalemia resident survival guide

Articles

Most recent articles on Hyperkalemia resident survival guide

Most cited articles on Hyperkalemia resident survival guide

Review articles on Hyperkalemia resident survival guide

Articles on Hyperkalemia resident survival guide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperkalemia resident survival guide

Images of Hyperkalemia resident survival guide

Photos of Hyperkalemia resident survival guide

Podcasts & MP3s on Hyperkalemia resident survival guide

Videos on Hyperkalemia resident survival guide

Evidence Based Medicine

Cochrane Collaboration on Hyperkalemia resident survival guide

Bandolier on Hyperkalemia resident survival guide

TRIP on Hyperkalemia resident survival guide

Clinical Trials

Ongoing Trials on Hyperkalemia resident survival guide at Clinical Trials.gov

Trial results on Hyperkalemia resident survival guide

Clinical Trials on Hyperkalemia resident survival guide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperkalemia resident survival guide

NICE Guidance on Hyperkalemia resident survival guide

NHS PRODIGY Guidance

FDA on Hyperkalemia resident survival guide

CDC on Hyperkalemia resident survival guide

Books

Books on Hyperkalemia resident survival guide

News

Hyperkalemia resident survival guide in the news

Be alerted to news on Hyperkalemia resident survival guide

News trends on Hyperkalemia resident survival guide

Commentary

Blogs on Hyperkalemia resident survival guide

Definitions

Definitions of Hyperkalemia resident survival guide

Patient Resources / Community

Patient resources on Hyperkalemia resident survival guide

Discussion groups on Hyperkalemia resident survival guide

Patient Handouts on Hyperkalemia resident survival guide

Directions to Hospitals Treating Hyperkalemia resident survival guide

Risk calculators and risk factors for Hyperkalemia resident survival guide

Healthcare Provider Resources

Symptoms of Hyperkalemia resident survival guide

Causes & Risk Factors for Hyperkalemia resident survival guide

Diagnostic studies for Hyperkalemia resident survival guide

Treatment of Hyperkalemia resident survival guide

Continuing Medical Education (CME)

CME Programs on Hyperkalemia resident survival guide

International

Hyperkalemia resident survival guide en Espanol

Hyperkalemia resident survival guide en Francais

Business

Hyperkalemia resident survival guide in the Marketplace

Patents on Hyperkalemia resident survival guide

Experimental / Informatics

List of terms related to Hyperkalemia resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate editor-in-chief: Mahmoud Sakr, M.D. [2]

Definition

Hyperkalemia is defined as a serum potassium concentration greater than 5.5 mEq/L in adults. Levels higher than 7 mEq/L can lead to significant hemodynamic compromise.

Causes

  • Hyperkalemia is most commonly caused by increased intake, impaired renal excretion, or rapid transcellular shift.

Life-Threatening Causes

Life-threatening here means a condition that can lead to death or permanent disability within 24 hours.

Common Causes

Management

Shown below is an algorithm summarizing the approach to hyperkalemia.

 
 
 
 
 
 
 
 
Check vital signs
Stabilize the patient
Order an EKG
Concise history and physical exam
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess EKG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EKG changes;e.g. hyperacute T waves, widened QRS,
 
 
 
 
 
 
 
 
 
 
EKG not changed, patient stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use rapidly acting transient agents, e.g Insulin, Dextrose, IV Calcium; with Ca gluconate generally preferred over Ca chloride, inhaled Beta2 agonists
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kayexalate, orally, and also can be given rectally in unconscious patients to avoid risks of aspiration
 
 
 
IV hydration
 
 
 
Stop potential causative medications
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use carefully in potential heart failure patients,
consider diuresis when clinically appropriate
 
 
 
Consult with nephrology for resistant and severe cases of hyperkalemia
may require urgent dialysis, yet rare
 

Do's and Don'ts

  • Place the patient on a closely monitored bed for potential fatal arrhythmias, esp. with levels higher than 6.5.
  • Repeat basic metabolic panels frequently.
  • Be ware when using kayexalate, as it has been reported to cause colonic transmural necrosis.[1]
  • Remove the offending medications that are associated with hyperkalemia.
  • Keep the patient well hydrated.
  • Check levels of other electrolytes such as Magnesium and phosphorus as it may be abnormal as well.
  • Avoid over treating with IV bicarbonate as it may lead to rebound metabolic alkalosis.
  • Consider consultation with nephrology.

References

  1. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM (1987). "Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis". Surgery. 101 (3): 267–72. PMID 3824154.


Template:WikiDoc Sources